Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05272371
Status:
RECRUITING
Last Update Posted:
2022-03-09
First Post:
2022-03-01
Brief Title:
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease
Sponsor:
Jagiellonian University
Organization:
Jagiellonian University
Organization Data
Organization:
Jagiellonian University
Class:
OTHER
Study ID:
ChIm-NB-PL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jagiellonian University
Lead Sponsor Class:
OTHER
Responsible Party:
Walentyna Balwierz
Responsible Party Title:
Prof
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Jagiellonian University
Old Name:
None
Old Organization:
None